Bushehr Elderly Health (BEH)

Programme, phase I (cardiovascular

system) by Noroozi, Azita et al.
Bushehr Elderly Health (BEH)
Programme, phase I (cardiovascular
system)
Afshin Ostovar,1 Iraj Nabipour,2 Bagher Larijani,3 Ramin Heshmat,4
Hossein Darabi,1 Katayoun Vahdat,1 Maryam Ravanipour,1 Neda Mehrdad,5
Alireza Raeisi,1 Gholamreza Heidari,1 Gita Shafiee,4 Mohammadjavad Haeri,1
Mohammadreza Pourbehi,2 Farshad Sharifi,5 Azita Noroozi,1 Rahim Tahmasebi,1
Hamidreza Aghaei Meybodi,6 Majid Assadi,7 Shokrollah Farrokhi,7 Reza Nemati,7
Mohammad Reza Amini,3 Maryam Barekat,1 Abdullatif Amini,1
Houman Salimipour,1 Sina Dobaradaran,2 Darab Moshtaghi1
To cite: Ostovar A,
Nabipour I, Larijani B, et al.
Bushehr Elderly Health (BEH)
Programme, phase I
(cardiovascular system). BMJ
Open 2015;5:e009597.
doi:10.1136/bmjopen-2015-
009597
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-009597).
This study is being carried
out at The Persian Gulf
Tropical Medicine Research
Centre, which is affiliated
with Bushehr University of
Medical Sciences, in
Bushehr, Iran.
Received 7 August 2015
Revised 22 October 2015
Accepted 26 October 2015
For numbered affiliations see
end of article.
Correspondence to
Professor Iraj Nabipour;
inabipour@gmail.com
ABSTRACT
Purpose: The main objective of the Bushehr Elderly
Health Programme, in its first phase, is to investigate
the prevalence of cardiovascular risk factors and their
association with major adverse cardiovascular events.
Participants: Between March 2013 and October
2014, a total of 3000 men and women aged
≥60 years, residing in Bushehr, Iran, participated in
this prospective cohort study (participation
rate=90.2%).
Findings to date: Baseline data on risk factors,
including demographic and socioeconomic status,
smoking and medical history, were collected through a
modified WHO MONICA questionnaire. Vital signs and
anthropometric measures, including systolic and
diastolic blood pressure, weight, height, and waist and
hip circumference, were also measured. 12-lead
electrocardiography and echocardiography were
conducted on all participants, and total of 10 cc
venous blood was taken, and sera was separated and
stored at –80°C for possible future use. Preliminary
data analyses showed a noticeably higher prevalence of
risk factors among older women compared to that in
men.
Future plans: Risk factor assessments will be
repeated every 5 years, and the participants will be
followed during the study to measure the occurrence
of major adverse cardiac events. Moreover, the second
phase, which includes investigation of bone health and
cognition in the elderly, was started in September
2015. Data are available at the Persian Gulf Biomedical
Research Institute, Bushehr University of Medical
Sciences, Bushehr, Iran, for any collaboration.
INTRODUCTION
The world’s population is ageing rapidly. The
proportion of those over the age of 60 years
will double, from about 11% to 22%,
between 2000 and 2050. The absolute
number of people aged 60 years and over is
expected to increase from 605 million to 2
billion over the same period.1 According to
the latest Iranian Census Data, about 8.2% of
the population was over 60 years of age in
2011.2 By the year 2020, the elderly popula-
tion (over 60 years of age) is estimated to
reach 10%.
Coronary heart disease (CHD) is one of
the leading causes of disease burden in
developing countries. In other words, three-
fourths of global deaths due to CHD
occurred in low-income and middle-income
countries.3 In the year 2003, there were
21 572 Disability Adjusted Lost Years
(DALYs) due to all diseases and injuries per
100 000 Iranian people of all ages and both
sexes. From this total number of DALYs, 58%
were due to non-communicable diseases;
ischaemic heart disease was the fourth cause
of DALYs in males and the ﬁrst cause of
DALYs in females.4
There is a need for effective public health
action on cardiovascular disease (CVD) pre-
vention, especially in low-income and
middle-income countries, and for assess-
ments of the cost-effectiveness of feasible
Strengths and limitations of this study
▪ This is the first large sample prospective cohort
study in Iran focusing on cardiovascular risk
factors in the elderly as a growing population.
▪ The long-term follow-up in this study will allow
for the assessment of many relevant outcomes.
▪ The participation rate in this study was high;
however, outcome ascertainment may be incom-
plete because of incomplete death and MACE
registries.
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interventions.5 In addition, there is a need to try to
balance the ﬁght against the existing burden of infec-
tious diseases with the growing epidemic of chronic dis-
eases such as heart disease and diabetes.6 The high costs
of direct medical care and the indirect costs of CVD,
according to the American Heart Association, were
approaching $450 billion annually in 2010 and were pro-
jected to rise to over $1 trillion annually by 2030.7
Prevention of premature deaths due to non-
communicable diseases and the reduction of related
healthcare costs should be the main goals of health
policy. Improving the detection and treatment of non-
communicable diseases, and preventing complications
and catastrophic events from occurring, should be the
major goals of clinical medicine.8 Trends in CVD risk
factors and blood glucose will result in substantial CVD
burden in developing countries and economies in transi-
tion in the near future. Periodic and consistent monitor-
ing of trends and the effects of these risk factors on
disease burden is needed for prioritising prevention
programmes.9
In recent decades, cohort studies have played a major
role in investigating the incidence and causes of
common health outcomes. As major adverse cardiovas-
cular events (MACE) are quite common in old age,
there are many cohort studies investigating these out-
comes. A vast majority of these cohort studies are being
conducted in developed countries.10–20 However, the
number of such prospective studies in the developing
world is also rising.21–25 In Iran, there are a few large
prospective studies being conducted in various ﬁelds.
Golestan’s cohort study, a prospective study of oesopha-
geal cancer in northern Iran,26 the Tehran Lipid and
Glucose Study (TLGS)27 and the Shahrood Eye Cohort
Study (ShECS),28 are among these studies. The
Amirkola Health and Ageing Project (AHAP) is the only
large sample prospective cohort study in Iran, speciﬁc-
ally aimed at investigating falling, bone fragility and frac-
tures, cognitive impairment and dementia, poor
mobility and functional dependence in the elderly.29
This paper describes the rationale for, design and pre-
liminary results of the Bushehr Elderly Health (BEH)
Programme, a population-based prospective cohort
study conducted in Bushehr, a southern province of
Iran. The main objective of this study, in its ﬁrst phase,
is to investigate the prevalence of cardiovascular risk
factors and their association to MACE.
COHORT DESCRIPTION
The target population of this prospective cohort study
was all men and women aged 60 years and over residing
in the city of Bushehr. Based on the information avail-
able from the Bushehr District Health Centre, this popu-
lation was estimated to be around 10 000. Box 1 shows
eligibility criteria for participation in the study.
The participants in the BEH Programme were selected
through a multistage, stratiﬁed cluster random sampling
method. Based on the classiﬁcations made by the muni-
cipality, as shown in ﬁgure 1, we stratiﬁed Bushehr to 75
strata. Numbers were assigned to the blocks (as clusters)
of each stratum and then randomly sorted. We invited
all eligible older people residing in each block selected
to participate and then moved to the next block, repeat-
ing the invitation process, until we gained the sample
Box 1 List of inclusion and exclusion criteria of
participants
Inclusion criteria
▸ Age more than or equal to 60 years
▸ Both sexes
▸ Residency in Bushehr port since at least 1 year prior to the
recruitment
▸ No plan to leave Bushehr for the following 2 years after the
recruitment
▸ Adequate physical and mental ability to participate in the
evaluation programme
▸ Signing of written informed consent
Exclusion criteria
▸ No residence in Bushehr
▸ Unwilling to participate in the study
Figure 1 Map of Bushehr and distribution of participants in
the strata.
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required for that stratum. Sample sizes for strata were
determined proportional to the number of households
residing in each stratum. As shown in ﬁgure 2, between
March 2013 and October 2014, from among 3297 older
people aged 60 years and over who were invited, a total
of 3000 participated in this study (participation rate:
91.0%). Non-respondents were found among all strata,
and there was no obvious pattern indicating selection
bias. Baseline characteristics of participants are shown in
table 1.
The main follow-up assessments of risk factors will be
carried out every 5 years for three consecutive periods
(a total of 15 years of follow-up), in which all assess-
ments will be repeated with comparable methods and
modalities.
In addition, interim assessments will be made to ascer-
tain outcomes and risk factor changes.
All participants will be contacted by a trained nurse
once annually, and a checklist will be completed to check
if any outcome of interest (major adverse cardiac events)
has occurred during the 12 months prior to the assess-
ment. A form has also been distributed to the partici-
pants to self-report as soon as possible after the
occurrence of any of the targeted outcomes. Focal points
in the two main hospitals in Bushehr (Shohadaye-
Khalij-e-Fars and Salman-e-Farsi hospitals) are respon-
sible for monthly checking of the hospital information
system (HIS) and reporting admissions. If any outcome is
reported, a general physician will review the inpatient/
outpatient medical records and documents, and detailed
information will be entered into the special outcome
forms. Our database will be cross-linked with the death
registry system database, available via the public health
system. The death registry system receives information
from hospitals, forensic medicine departments, cemeter-
ies and vital events records ofﬁces, and duplicate records
are deleted. The International Classiﬁcation of Diseases
(ICD) 10, WHO online version, is used to classify causes
of death. A person’s national identiﬁcation number is
used as a unique identiﬁer to cross-link databases. In the
case of a death report but no reliable death certiﬁcate, a
verbal autopsy will be performed to determine cause of
death. Box 2 presents list of outcomes ascertained in the
present study.
Baseline examination
A modiﬁed WHO MONICA questionnaire30 translated
into Persian was used as the core questionnaire to
gather baseline information on demographic and socio-
economic variables and risk factors. Table 2 presents the
components of the core questionnaire.
Phlebotomy and laboratory analyses
Participants were asked to provide a venous blood
sample for laboratory tests. A total of 10 cc of whole
Table 1 Baseline sociodemographic characteristics of
participants in Bushehr Elderly Health Programme
Characteristics
(N (%))
Men
(1455 (48.5))
Women
(1545 (51.5))
Age group (years)
≤64 616 (42.3) 674 (43.6)
65–69 317 (21.8) 378 (24.5)
70–74 230 (15.8) 200 (12.9)
75–79 166 (11.4) 181 (11.7)
≥80 126 (8.7) 112 (7.2)
Marital status
Single 5 (0.3) 20 (1.3)
Married 1378 (94.7) 884 (57.2
Widowed 68 (4.7) 619 (40.1)
Divorced 4 (0.3) 22 (1.4)
Current occupation
Employed 133 (9.1) 23 (1.5)
Retired 1195 (82.1) 126 (8.2)
Unemployed* 127 (8.7) 1396 (90.4)
Education
No education 315 (21.6) 777 (50.3)
Primary school 400 (27.5) 459 (29.7)
Secondary School 276 (19.0) 151 (9.8)
High school 287 (19.7) 125 (8.1)
University 177 (12.2) 33 (2.1)
*Homemaker for female.
Figure 2 Flow chart of enrolments.
Box 2 List of outcomes, Bushehr Elderly Health
Programme study
▸ Death
▸ Myocardial infarction
▸ Stroke
▸ Cardiac interventions
▸ Hospital admission
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blood was taken by a trained nurse after 8–12 h of
fasting. Table 3 presents laboratory tests performed at
baseline and their methods of measurement. Sera were
also separated and stored at –80°C for possible future
use.
Clinical assessment
A comprehensive physical examination, including vital
signs, weight and height measurements, and waist and
hip circumference, were taken at baseline. Twelve-lead
electrocardiography, performed by a trained nurse, and
echocardiography, carried out by a cardiologist, were
conducted for all participants (see table 3).
FINDINGS TO DATE
Baseline data are being analysed, and preliminary ﬁnd-
ings are presented in table 4.31 The prevalence of car-
diovascular risk factors was remarkably higher among
older women compared to that in men. Smoking behav-
iour was different among older men and women. Older
women did not smoke cigarettes as often as men;
however, the prevalence of hookah smoking was higher
in women. One-third of older women were obese, which
was two times more than the prevalence of obesity
among men. Metabolic syndrome was also about two
times more prevalent among older women.
STRENGTHS AND LIMITATIONS
This is the ﬁrst large sample prospective cohort study in
Iran focusing on cardiovascular risk factors in the
elderly as a growing population. The long-term follow-up
in this study will allow for the assessment of many rele-
vant outcomes. The participation rate in this study was
high; however, outcome ascertainment may be incom-
plete because of incomplete death and MACE registries.
Table 2 Section and topics of the Core Questionnaire in
the Bushehr Elderly Health Programme study
Type of data Components
Demographic ▸ Personal information (name,
nickname, surname)
▸ National identification number
▸ Age and sex
▸ Marital status
▸ Contact information
Socioeconomic ▸ Employment status
▸ Education level
▸ Insurance
▸ Family income
▸ Family assets
▸ Residence status
Cardiovascular risk
factors and medical
history
▸ Smoking status and history
▸ Physical activity
▸ Menstrual and menopause history
▸ Blood pressure history
▸ Diabetes history
▸ Lipid profile history
▸ Ischaemia and myocardial
infarction history
▸ Weakness, impaired sensation
and stroke history
▸ Rose and claudication history
▸ Heart failure history
Drug history ▸ Administered by physician
▸ Over the counter drugs
▸ Supplements
Table 3 Baseline physical examinations and laboratory tests, Bushehr Elderly Health Programme study
Item Method of measurement
Physical examination
Arterial blood pressure Manually by standard mercury sphygmomanometer in sitting position
Weight in kg Stadiometer; heavy outer garments will be removed
Height in cm Stadiometer; shoes will be removed
Waist circumference in cm At the midway level between the costal margins and the iliac crests
Hip circumference in cm At the level of the greater trochanters
Laboratory tests
CBC Automated haematology analyser
Fasting blood sugar enzymatic (glucose oxidase) colourimetric method using a commercial kit (Pars
Azmun Inc, Tehran, Iran)
Lipid profile (total cholesterol,
LDL-C, HDL-C, triglyceride)
Serum total cholesterol and HDL cholesterol will be measured using a cholesterol
oxidase phenol aminoantipyrine and triglycerides using a glycerol-3-phosphate
oxidase phenol aminoantipyrine enzymatic method. Serum LDL cholesterol will be
calculated using the Friedwald formula; LDL cholesterol will not be calculated when
triglycerides concentration is >400 mg/dL
Procedures
Electrocardiography 12-lead, by a trained nurse
Echocardiography Using M-Turbo Ultrasound System, Manufactured by SonoSite, Inc, by a cardiologist
CBC, complete blood count; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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